SCHEMBL10145499

SCHEMBL10145499

CN(c1ccc(O)cc1)c1ccc2c3c(ccc2c1)C1(OC(=O)c2ccccc21)c1cc(Cl)c(O)cc1O3

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.48
FTO Q9C0B1 5/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
TDP1 Q9NUW8 4/20 0.48
HTT P42858 2/20 0.48
RECQL P46063 2/20 0.48
BLM P54132 2/20 0.48
PRMT1 Q99873 2/20 0.48
ACE2 Q9BYF1 2/20 0.48
CYP2C19 P33261 2/20 0.48
HPGD P15428 1/20 0.48
SMAD3 P84022 1/20 0.48
LMNA P02545 5/20 0.41
GPR55 Q9Y2T6 2/20 0.41
POLB P06746 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
GNG2 P59768 1/20 0.41
GNB1 P62873 1/20 0.41
ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29365877 0.88 FTO (0.57) MAPTFTOMEN1KMT2ATDP1
SCHEMBL5266530 0.88 FTO (0.57) MAPTFTOMEN1KMT2ATDP1
SCHEMBL10005881 0.82 FTO (0.64) MAPTFTOMEN1KMT2ATDP1
SCHEMBL5271242 0.81 FTO (0.60) MAPTFTOMEN1KMT2ATDP1
SCHEMBL10145679 0.80 CYP3A4 (0.43) MAPTFTOMEN1KMT2ATDP1
SCHEMBL29362878 0.79 FTO (0.73) MAPTFTOMEN1KMT2ATDP1
SCHEMBL5270629 0.79 FTO (0.73) MAPTFTOMEN1KMT2ATDP1
SCHEMBL4173117 0.78 FTO (0.79) MAPTFTOMEN1KMT2ATDP1
SCHEMBL29871701 0.78 FTO (0.79) MAPTFTOMEN1KMT2ATDP1
SCHEMBL10145477 0.78 MAPT (0.52) MAPTFTOMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8114904-B2 Luminescence quenchers and fluorogenic probes for detection of reactive species Versitech Limited & Morningside Ventures Limited (CN) 2012-02-14 US disclosed
US-8114904-B2 Luminescence quenchers and fluorogenic probes for detection of reactive species Versitech Limited & Morningside Ventures Limited (CN) 2012-02-14 US disclosed
US-20090253118-A1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES VERSITECH LIMITED (CN) 2009-10-08 US disclosed
US-20090253118-A1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES VERSITECH LIMITED (CN) 2009-10-08 US disclosed
WO-2009121247-A1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES VERSITECH LIMITED (CN) 2009-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253118-A1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES ROS1, LPO, HMOX1 MAPT 4349/4885FTO 244/4885MEN1 4478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.